Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOlfox6”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Large-scale testing (Phase 3)UnknownNCT00003260
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 109
Testing effectiveness (Phase 2)UnknownNCT03329183
What this trial is testing

High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28

Who this might be right for
Colorectal Cancer
Shanghai Changzheng Hospital 90
Testing effectiveness (Phase 2)Study completedNCT01619423
What this trial is testing

A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Advanced Metastatic (Stage IV) Colorectal Cancer
Egetis Therapeutics 186
Testing effectiveness (Phase 2)Study completedNCT00193219
What this trial is testing

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
SCRI Development Innovations, LLC 36
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Testing effectiveness (Phase 2)Study completedNCT01605305
What this trial is testing

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 60
Testing effectiveness (Phase 2)Study completedNCT01327612
What this trial is testing

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Who this might be right for
Advanced Solid TumorsCarcinoidColorectal Cancer+6 more
Amgen 12
Large-scale testing (Phase 3)Ended earlyNCT03654729
What this trial is testing

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Who this might be right for
Colorectal CancerChemotherapy-induced Peripheral Neuropathy
Egetis Therapeutics 291
Testing effectiveness (Phase 2)Study completedNCT00865709
What this trial is testing

Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

Who this might be right for
Metastatic Colorectal Cancer
Bayer 198
Testing effectiveness (Phase 2)Study completedNCT00862784
What this trial is testing

IMC-1121B (Ramucirumab) in Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Study completedNCT00591123
What this trial is testing

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Who this might be right for
Unresectable Adenocarcinoma of the EsophagusMetastatic Adenocarcinoma of the EsophagusUnresectable Adenocarcinoma of Gastric Cardia+1 more
Translational Oncology Research International 38
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Testing effectiveness (Phase 2)Study completedNCT01489865
What this trial is testing

ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Georgetown University 64
Large-scale testing (Phase 3)UnknownNCT01092481
What this trial is testing

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Who this might be right for
Colon Cancer
Samsung Medical Center 1,580
Testing effectiveness (Phase 2)UnknownNCT02887313
What this trial is testing

FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study

Who this might be right for
Rectal Cancer
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Study completedNCT01658033
What this trial is testing

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

Who this might be right for
Metastatic Breast Cancer
Fudan University 72
Early research (Phase 1)Study completedNCT00660153
What this trial is testing

Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers

Who this might be right for
Colorectal CancerGastrointestinal Cancer
AVEO Pharmaceuticals, Inc. 30
Early research (Phase 1)Study completedNCT00118261
What this trial is testing

Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Case Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT01666730
What this trial is testing

Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01851941
What this trial is testing

A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Seoul National University Hospital 52
Load More Results